Skip to main content
NCBI home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1991 Jun;66(6):689–692. doi: 10.1136/adc.66.6.689

Growth hormone treatment of growth failure secondary to total body irradiation and bone marrow transplantation.

A Papadimitriou 1, M Urena 1, G Hamill 1, R Stanhope 1, A D Leiper 1
PMCID: PMC1793144  PMID: 2053788

Abstract

Growth hormone was given to 13 children (nine boys, four girls) with acute leukaemia who had undergone treatment with cyclophosphamide and total body irradiation before bone marrow transplantation. Mean age at total body irradiation and bone marrow transplantation was 9.0 years (range 3.7-15.8). Endocrinological investigation was carried out at a mean of 2.0 years (range 0.4-4.0) after bone marrow transplantation. Peak serum growth hormone responses to hypoglycaemia were less than 10.0 micrograms/l (less than 20.0 mU/l) in 10, 10.5 micrograms/l (21.0 mU/l) in one, greater than 16.0 micrograms/l (greater than 32.0 mU/l) in two patients. Mean age of the patients at the start of growth hormone treatment was 12.2 years (range 5.8-18.2). The mean time between total body irradiation and bone marrow transplantation and the start of growth hormone treatment was 3.2 years (range, 1.1-5.0). Height velocity SD score (SD) increased from a mean pretreatment value of -1.27 (0.65) to + 0.22 (0.81) in the first year, +0.16 (1.11) in the second year, and +0.42 (0.71) in the third year of treatment. Height SD score (SD) changed only slightly from -1.52 (0.42) to -1.50 (0.47) in the first year, to -1.50 (0.46) in the second year, and -1.74 (0.92) in the third year. Measurement of segmental proportions showed no significant increase in subischial leg length from -0.87 (0.67) to -0.63 (0.65) in the first year, to -0.58 (0.70) in the second year, and -0.80 (1.14) in the third year of treatment. Our data indicate that children who have undergone total body irradiation and bone marrow transplantation respond to treatment with growth hormone in either of two dose regimens, with an increase in height velocity that is adequate to restore a normal growth rate but not to 'catch up', and that total body irradiation impairs not only spinal but also leg growth, possibly by a direct effect of irradiation on the epiphyses and soft tissues.

Full text

PDF
689

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chessells J. M., Leiper A. D., Tiedemann K., Hardisty R. M., Richards S. Oral methotrexate is as effective as intramuscular in maintenance therapy of acute lymphoblastic leukaemia. Arch Dis Child. 1987 Feb;62(2):172–176. doi: 10.1136/adc.62.2.172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Chessells J. M., Ninane J., Tiedemann K. Present problems in management of childhood lymphoblastic leukaemia: experience from the Hospital for Sick Children, London. Haematol Blood Transfus. 1981;26:108–114. doi: 10.1007/978-3-642-67984-1_16. [DOI] [PubMed] [Google Scholar]
  3. Clayton P. E., Shalet S. M., Price D. A. Growth response to growth hormone therapy following cranial irradiation. Eur J Pediatr. 1988 Aug;147(6):593–596. doi: 10.1007/BF00442470. [DOI] [PubMed] [Google Scholar]
  4. Clayton P. E., Shalet S. M., Price D. A. Growth response to growth hormone therapy following craniospinal irradiation. Eur J Pediatr. 1988 Aug;147(6):597–601. doi: 10.1007/BF00442471. [DOI] [PubMed] [Google Scholar]
  5. Cowell C. T., Quigley C. A., Moore B., Kirk J. A., Bergin M., Jimenez M., Stevens M. M., Howard N. J., Menser M. A., Silink M. Growth and growth hormone therapy of children treated for leukaemia. Acta Paediatr Scand Suppl. 1988;343:152–161. doi: 10.1111/j.1651-2227.1988.tb10816.x. [DOI] [PubMed] [Google Scholar]
  6. Deeg H. J., Storb R., Thomas E. D. Bone marrow transplantation: a review of delayed complications. Br J Haematol. 1984 Jun;57(2):185–208. [PubMed] [Google Scholar]
  7. Lannering B., Marky I., Mellander L., Albertsson-Wikland K. Growth hormone secretion and response to growth hormone therapy after treatment for brain tumour. Acta Paediatr Scand Suppl. 1988;343:146–151. doi: 10.1111/j.1651-2227.1988.tb10815.x. [DOI] [PubMed] [Google Scholar]
  8. Leiper A. D., Grant D. B., Chessells J. M. Gonadal function after testicular radiation for acute lymphoblastic leukaemia. Arch Dis Child. 1986 Jan;61(1):53–56. doi: 10.1136/adc.61.1.53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Leiper A. D., Stanhope R., Lau T., Grant D. B., Blacklock H., Chessells J. M., Plowman P. N. The effect of total body irradiation and bone marrow transplantation during childhood and adolescence on growth and endocrine function. Br J Haematol. 1987 Dec;67(4):419–426. doi: 10.1111/j.1365-2141.1987.tb06163.x. [DOI] [PubMed] [Google Scholar]
  10. Milner R. D. Proper use of growth hormone. Arch Dis Child. 1990 Jan;65(1):70–71. doi: 10.1136/adc.65.1.70. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Mott M. G., Chessells J. M., Willoughby M. L., Mann J. R., Morris-Jones P. H., Malpas J. S., Palmer M. K. Adjuvant low dose radiation in childhood T cell leukaemia/lymphoma (report from the United Kingdom Childrens' Cancer Study Group--UKCCSG). Br J Cancer. 1984 Oct;50(4):457–462. doi: 10.1038/bjc.1984.201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Probert J. C., Parker B. R., Kaplan H. S. Growth retardation in children after megavoltage irradiation of the spine. Cancer. 1973 Sep;32(3):634–639. doi: 10.1002/1097-0142(197309)32:3<634::aid-cncr2820320316>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  13. Probert J. C., Parker B. R. The effects of radiation therapy on bone growth. Radiology. 1975 Jan;114(1):155–162. doi: 10.1148/114.1.155. [DOI] [PubMed] [Google Scholar]
  14. Sanders J. E., Pritchard S., Mahoney P., Amos D., Buckner C. D., Witherspoon R. P., Deeg H. J., Doney K. C., Sullivan K. M., Appelbaum F. R. Growth and development following marrow transplantation for leukemia. Blood. 1986 Nov;68(5):1129–1135. [PubMed] [Google Scholar]
  15. Shalet S. M., Clayton P. E., Price D. A. Growth impairment following treatment for childhood brain tumours. Acta Paediatr Scand Suppl. 1988;343:137–145. doi: 10.1111/j.1651-2227.1988.tb10814.x. [DOI] [PubMed] [Google Scholar]
  16. Shalet S. M., Whitehead E., Chapman A. J., Beardwell C. G. The effects of growth hormone therapy in children with radiation-induced growth hormone deficiency. Acta Paediatr Scand. 1981 Jan;70(1):81–86. doi: 10.1111/j.1651-2227.1981.tb07177.x. [DOI] [PubMed] [Google Scholar]
  17. Tanner J. M., Whitehouse R. H., Takaishi M. Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. II. Arch Dis Child. 1966 Dec;41(220):613–635. doi: 10.1136/adc.41.220.613. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES